Literature DB >> 9923592

Hepatitis B core particles as a universal display model: a structure-function basis for development.

P Pumpens1, E Grens.   

Abstract

Because it exhibits a remarkable capability to accept mutational intervention and undergo correct folding and self-assembly in all viable prokaryotic and eukaryotic expression systems, hepatitis B core (HBc) protein has been favored over other proposed particulate carriers. Structurally, the unusual alpha-helical organization of HBc dimeric units allows introduction of foreign peptide sequences into several areas of HBc shells, including their most protruding spikes. Progress toward full resolution of the spatial structure as well as accumulation of chimeric HBc-based structures has brought closer the knowledge-based design of future vaccines, gene therapy tools and other artificial particulate objects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9923592     DOI: 10.1016/s0014-5793(98)01599-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

Review 1.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

2.  Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrier.

Authors:  Jia-Yu Chen; Fan Li
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

3.  Critical role of the 36-nucleotide insertion in hepatitis B virus genotype G in core protein expression, genome replication, and virion secretion.

Authors:  Ke Li; Fabien Zoulim; Christian Pichoud; Karen Kwei; Stéphanie Villet; Jack Wands; Jisu Li; Shuping Tong
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

4.  Polyvalent display of heme on hepatitis B virus capsid protein through coordination to hexahistidine tags.

Authors:  Duane E Prasuhn; Jane Kuzelka; Erica Strable; Andrew K Udit; So-Hye Cho; Gabriel C Lander; Joel D Quispe; James R Diers; David F Bocian; Clint Potter; Bridget Carragher; M G Finn
Journal:  Chem Biol       Date:  2008-05

Review 5.  Therapeutic vaccines for chronic diseases: successes and technical challenges.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

Review 6.  Precore/core region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Seung Yeon Do; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

7.  A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.

Authors:  A Birkett; K Lyons; A Schmidt; D Boyd; G A Oliveira; A Siddique; R Nussenzweig; J M Calvo-Calle; E Nardin
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly.

Authors:  Hee Yong Kang; Seungkeun Lee; Sung Gyoo Park; Jaehoon Yu; Youngsoo Kim; Guhung Jung
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

Review 9.  Soluble recombinant influenza vaccines.

Authors:  W Fiers; S Neirynck; T Deroo; X Saelens; W M Jou
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

10.  Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.

Authors:  Claire L Hutchings; Ashley J Birkett; Anne C Moore; Adrian V S Hill
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.